The biotechnology company HANXBIO-B (03378) has executed a share repurchase transaction. On June 8, 2026, the company allocated HK$1.6785 million to buy back 62,400 of its own shares.
The repurchase was conducted at prices ranging between HK$25.94 and HK$28 per share.